WallStreetZenWallStreetZen

NASDAQ: SEEL
Seelos Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

SEEL past revenue growth

How has SEEL's revenue growth performed historically?
Company
N/A
Industry
145.73%
Market
17.2%
SEEL's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
SEEL's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance

SEEL earnings and revenue history

Current Revenue
$2.2M
Current Earnings
-$37.9M
Current Profit Margin
-1,719.6%

SEEL Return on Equity

Current Company
N/A
Current Industry
-63.5%
Current Market
188%

Be the first to know when SEEL announces earnings.

SEEL Return on Assets

Current Company
-321.3%
Current Industry
2.9%
SEEL is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

SEEL Return on Capital Employed

Current Company
112.82%
Current Industry
19.5%
SEEL has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

SEEL vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
SEEL$2.20M-$37.75M-$37.88M+55.68%N/A
ENSC$0.00-$10.26M-$10.63MN/AN/A
CMND$0.00-$7.85M-$8.09MN/AN/A
GNPX$0.00-$30.85M-$30.86MN/AN/A
TCON$12.05M$3.75M-$3.59M+32.05%N/A
View Top Biotech Stocks

SEEL earnings dates

Next earnings date
May 17, 2024

Seelos Therapeutics Earnings & Revenue FAQ

What were SEEL's earnings last quarter?

On Invalid Date, Seelos Therapeutics (NASDAQ: SEEL) reported Q4 2023 earnings per share (EPS) of $0.07, up 101.36% year over year. Total Seelos Therapeutics earnings for the quarter were -$5.45 million. In the same quarter last year, Seelos Therapeutics's earnings per share (EPS) was -$5.14.

If you're new to stock investing, here's how to buy Seelos Therapeutics stock.

What was SEEL's earnings growth in the past year?

As of Q2 2024, Seelos Therapeutics's earnings has grown year over year. Seelos Therapeutics's earnings in the past year totalled -$37.88 million.

What is SEEL's earnings date?

Seelos Therapeutics's earnings date is Invalid Date. Add SEEL to your watchlist to be reminded of SEEL's next earnings announcement.

What was SEEL's revenue last quarter?

On Invalid Date, Seelos Therapeutics (NASDAQ: SEEL) reported Q4 2023 revenue of $653.00 thousand up Infinity% year over year. In the same quarter last year, Seelos Therapeutics's revenue was $0.00.

What was SEEL's revenue growth in the past year?

As of Q2 2024, Seelos Therapeutics's revenue has grown null year over year. Seelos Therapeutics's revenue in the past year totalled $2.20 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.